Therapeutic Asset Ratings

Zn-A-1041

abp1011t

Ametinib

bay2927088

cvl237 tablets

Docetaxel Polymeric Micelles For

Fam-Trastuzumab Deruxtecan-Nxki

Lazertinib

Shr-4602

S^3.15,S^3.22,S^3.29-[(1,3,5-triazinane-1,3,5-triyl)tris(3-oxopropane-3,1-diyl)]{N-[5-oxo-5-({L-valyl-N⁵-carbamoyl-L-ornithyl[(4-aminophenyl)methoxy]carbonyl-N-methyl-L-valyl-Lvalyl-(3R,4S,5S)-3-methoxy-5-methyl-4-(methylamino)heptanoyl-(2R,3R)-N-[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]-3-methoxy-2-methyl-3-[(2S)-pyrrolidin-2-yl]propanamide}-N2.1-yl)pentanoyl]-?-alanyldecakis(N-methylglycyl)-L-alanyl-N6-carbamimidoyl-L-lysyl-L-?-aspartyl-L-cysteinyl-(4R)-4-hydroxy-L-prolyl-L-leucyl-L-valyl-L-asparaginyl-L-prolyl-L-leucyl-L-cysteinyl-L-leucyl-L-histidyl-L-prolyl-D-?-aspartyl-L-tryptophyl-N6-carbamimidoyl-L-lysyl-Lcysteinamide}

Vabametkib

Rosuvastatin

Veliparib

Bosutinib

Chir-258

AK 127

bat8008

Daraxonrasib

hs-10370

human vascular endothelial growth factor receptor 1 (VEGFR-1) fragment 129-228 comprising the second extracellular domain of the VEGF receptor (VEGFR-D2), [N¹⁹⁶>A⁶⁸]-variant, anti-(human vascular endothelial growth factor (VEGF) (1-100 in the current sequence) fused, via a (G4S)3 peptide linker (101-115), to gamma 1 heavy chain (116-563) [VH (Homo sapiens IGHV3-23*04 -(IGHD) -IGHJ4*01, CDR-Kabat [5.17.9] (146-150.165-181.214-222)) (116-233) -Homo sapiens IGHG1*03 (CH1 (234-331), hinge (332-346), CH2 S⁴¹⁴>A, E⁴⁴⁹>A, K⁴⁵⁰>A (347-456), CH3 (457-561), CHS (562-563)) (234-563)], (336-214')-disulfide with kappa light chain (1'-214') [V-KAPPA (Homo sapiens IGKV1-12*01 -IGKJ1*01, CDRKabat [11.7.9] (24'-34'.50'-56'.89'-97')) (1'-107') -Homo sapiens IGKC*01 (108'-214')]; dimer (342-342'', 345-345'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-K1, glycoform alfa

kxv01 tcr lentinvivo

qls5132

Rapamycin

Rmc-6236

sys6043